| Product Code: ETC7629126 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Ireland Emetogenic Drugs Market Overview |
3.1 Ireland Country Macro Economic Indicators |
3.2 Ireland Emetogenic Drugs Market Revenues & Volume, 2021 & 2031F |
3.3 Ireland Emetogenic Drugs Market - Industry Life Cycle |
3.4 Ireland Emetogenic Drugs Market - Porter's Five Forces |
3.5 Ireland Emetogenic Drugs Market Revenues & Volume Share, By Class, 2021 & 2031F |
3.6 Ireland Emetogenic Drugs Market Revenues & Volume Share, By Types of Emesis, 2021 & 2031F |
3.7 Ireland Emetogenic Drugs Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.8 Ireland Emetogenic Drugs Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.9 Ireland Emetogenic Drugs Market Revenues & Volume Share, By End user, 2021 & 2031F |
4 Ireland Emetogenic Drugs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer and other chronic diseases that require chemotherapy, leading to higher demand for emetogenic drugs. |
4.2.2 Growing geriatric population in Ireland, who are more prone to conditions requiring chemotherapy and subsequently emetogenic drugs. |
4.2.3 Advancements in healthcare infrastructure and facilities in Ireland, improving accessibility to emetogenic drugs. |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for approval and marketing of emetogenic drugs in Ireland, leading to delays in product launches. |
4.3.2 High costs associated with emetogenic drugs, limiting affordability for certain patient segments. |
5 Ireland Emetogenic Drugs Market Trends |
6 Ireland Emetogenic Drugs Market, By Types |
6.1 Ireland Emetogenic Drugs Market, By Class |
6.1.1 Overview and Analysis |
6.1.2 Ireland Emetogenic Drugs Market Revenues & Volume, By Class, 2021- 2031F |
6.1.3 Ireland Emetogenic Drugs Market Revenues & Volume, By Serotonin Receptor Antagonists (5-HT3 RAS), 2021- 2031F |
6.1.4 Ireland Emetogenic Drugs Market Revenues & Volume, By Neurokinin-1 Receptor Antagonist (NK1 RAS), 2021- 2031F |
6.1.5 Ireland Emetogenic Drugs Market Revenues & Volume, By 5HT3 RA/NK1 RA Combination, 2021- 2031F |
6.1.6 Ireland Emetogenic Drugs Market Revenues & Volume, By Corticosteroids, 2021- 2031F |
6.1.7 Ireland Emetogenic Drugs Market Revenues & Volume, By Olanzapine, 2021- 2031F |
6.1.8 Ireland Emetogenic Drugs Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Ireland Emetogenic Drugs Market, By Types of Emesis |
6.2.1 Overview and Analysis |
6.2.2 Ireland Emetogenic Drugs Market Revenues & Volume, By Acute, 2021- 2031F |
6.2.3 Ireland Emetogenic Drugs Market Revenues & Volume, By Delayed, 2021- 2031F |
6.2.4 Ireland Emetogenic Drugs Market Revenues & Volume, By Anticipatory, 2021- 2031F |
6.2.5 Ireland Emetogenic Drugs Market Revenues & Volume, By Breakthrough, 2021- 2031F |
6.2.6 Ireland Emetogenic Drugs Market Revenues & Volume, By Refactory, 2021- 2031F |
6.2.7 Ireland Emetogenic Drugs Market Revenues & Volume, By Chronic, 2021- 2031F |
6.3 Ireland Emetogenic Drugs Market, By Application |
6.3.1 Overview and Analysis |
6.3.2 Ireland Emetogenic Drugs Market Revenues & Volume, By Highly Emetogenic Chemotherapy, 2021- 2031F |
6.3.3 Ireland Emetogenic Drugs Market Revenues & Volume, By Moderately Emetogenic Chemotherapy, 2021- 2031F |
6.3.4 Ireland Emetogenic Drugs Market Revenues & Volume, By Low Emetogenic Chemotherapy, 2021- 2031F |
6.3.5 Ireland Emetogenic Drugs Market Revenues & Volume, By Other, 2021- 2031F |
6.4 Ireland Emetogenic Drugs Market, By Drug Type |
6.4.1 Overview and Analysis |
6.4.2 Ireland Emetogenic Drugs Market Revenues & Volume, By Branded, 2021- 2031F |
6.4.3 Ireland Emetogenic Drugs Market Revenues & Volume, By Generic, 2021- 2031F |
6.5 Ireland Emetogenic Drugs Market, By End user |
6.5.1 Overview and Analysis |
6.5.2 Ireland Emetogenic Drugs Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.5.3 Ireland Emetogenic Drugs Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.5.4 Ireland Emetogenic Drugs Market Revenues & Volume, By Others, 2021- 2031F |
7 Ireland Emetogenic Drugs Market Import-Export Trade Statistics |
7.1 Ireland Emetogenic Drugs Market Export to Major Countries |
7.2 Ireland Emetogenic Drugs Market Imports from Major Countries |
8 Ireland Emetogenic Drugs Market Key Performance Indicators |
8.1 Patient adherence rate to emetogenic drug therapy. |
8.2 Number of healthcare facilities offering emetogenic drug administration services. |
8.3 Rate of adoption of innovative emetogenic drug formulations in the market. |
9 Ireland Emetogenic Drugs Market - Opportunity Assessment |
9.1 Ireland Emetogenic Drugs Market Opportunity Assessment, By Class, 2021 & 2031F |
9.2 Ireland Emetogenic Drugs Market Opportunity Assessment, By Types of Emesis, 2021 & 2031F |
9.3 Ireland Emetogenic Drugs Market Opportunity Assessment, By Application, 2021 & 2031F |
9.4 Ireland Emetogenic Drugs Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.5 Ireland Emetogenic Drugs Market Opportunity Assessment, By End user, 2021 & 2031F |
10 Ireland Emetogenic Drugs Market - Competitive Landscape |
10.1 Ireland Emetogenic Drugs Market Revenue Share, By Companies, 2024 |
10.2 Ireland Emetogenic Drugs Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here